BACKGROUND: Lung transplant recipients undergo bronchoalveolar lavage (BAL) to detect antecedents of chronic lung allograft dysfunction (CLAD), but routine assessment of BAL cytology is controversial. We hypothesized that inflammation on BAL cytology would predict CLAD-free survival. METHODS: In a single-center retrospective cohort, associations between cytology results and clinical characteristics were compared using generalized-estimating equation-adjusted regression. The association between BAL inflammation and CLAD or death risk was assessed using time-dependent Cox models. RESULTS: In 3365 cytology reports from 451 subjects, inflammation was the most common finding (6.2%, 210 cases), followed by fungal forms (5.3%, 178 cases, including 24 cases of suspected Aspergillus). Inflammation on BAL cytology was more common in procedures for symptoms (8.5%) versus surveillance (3.2%, p < .001). Inflammation on cytology was associated with automated neutrophil and lymphocyte counts, acute cellular rejection, infection, and portended a 2.2-fold hazard ratio (CI 1.2-4.0, p = .007) for CLAD or death. However, inflammation by cytology did not inform CLAD-free survival risk beyond automated BAL cell counts (p = .57). CONCLUSIONS: Inflammation on BAL cytology is clinically significant, suggesting acute rejection or infection and increased risk of CLAD or death. However, other indicators of allograft inflammation can substitute for much of the information provided by BAL cytology.
BACKGROUND: Lung transplant recipients undergo bronchoalveolar lavage (BAL) to detect antecedents of chronic lung allograft dysfunction (CLAD), but routine assessment of BAL cytology is controversial. We hypothesized that inflammation on BAL cytology would predict CLAD-free survival. METHODS: In a single-center retrospective cohort, associations between cytology results and clinical characteristics were compared using generalized-estimating equation-adjusted regression. The association between BAL inflammation and CLAD or death risk was assessed using time-dependent Cox models. RESULTS: In 3365 cytology reports from 451 subjects, inflammation was the most common finding (6.2%, 210 cases), followed by fungal forms (5.3%, 178 cases, including 24 cases of suspected Aspergillus). Inflammation on BAL cytology was more common in procedures for symptoms (8.5%) versus surveillance (3.2%, p < .001). Inflammation on cytology was associated with automated neutrophil and lymphocyte counts, acute cellular rejection, infection, and portended a 2.2-fold hazard ratio (CI 1.2-4.0, p = .007) for CLAD or death. However, inflammation by cytology did not inform CLAD-free survival risk beyond automated BAL cell counts (p = .57). CONCLUSIONS: Inflammation on BAL cytology is clinically significant, suggesting acute rejection or infection and increased risk of CLAD or death. However, other indicators of allograft inflammation can substitute for much of the information provided by BAL cytology.
Authors: Daniel R Calabrese; Tiffany Chong; Angelia Wang; Jonathan P Singer; Marc Gottschall; Steven R Hays; Jeffrey A Golden; Jasleen Kukreja; Lewis L Lanier; Qizhi Tang; John R Greenland Journal: Transplantation Date: 2019-03 Impact factor: 4.939
Authors: B DiGiovine; J P Lynch; F J Martinez; A Flint; R I Whyte; M D Iannettoni; D A Arenberg; M D Burdick; M C Glass; C A Wilke; S B Morris; S L Kunkel; R M Strieter Journal: J Immunol Date: 1996-11-01 Impact factor: 5.422
Authors: Stijn E Verleden; David Ruttens; Elly Vandermeulen; Dirk E van Raemdonck; Bart M Vanaudenaerde; Geert M Verleden; Robin Vos Journal: Transplantation Date: 2014-01-15 Impact factor: 4.939
Authors: Tereza Martinu; Angela Koutsokera; Christian Benden; Edward Cantu; Daniel Chambers; Marcelo Cypel; Jeffrey Edelman; Amir Emtiazjoo; Andrew J Fisher; John R Greenland; Don Hayes; David Hwang; Brian C Keller; Erika D Lease; Michael Perch; Masaaki Sato; Jamie L Todd; Stijn Verleden; Jan von der Thüsen; S Samuel Weigt; Shaf Keshavjee Journal: J Heart Lung Transplant Date: 2020-07-15 Impact factor: 10.247
Authors: J R Greenland; N P Jewell; M Gottschall; N N Trivedi; J Kukreja; S R Hays; J P Singer; J A Golden; G H Caughey Journal: Am J Transplant Date: 2014-02-11 Impact factor: 8.086
Authors: Claus Neurohr; Patrick Huppmann; Benedikt Samweber; Stefan Leuschner; Gregor Zimmermann; Hanno Leuchte; Rainer Baumgartner; Rudolf Hatz; Ludwig Frey; Peter Ueberfuhr; Iris Bittmann; Juergen Behr Journal: J Heart Lung Transplant Date: 2009-03-14 Impact factor: 10.247
Authors: Jonathan Hoover; Michelle A Mintz; Fred Deiter; Emily Aminian; Joy Chen; Steven R Hays; Jonathan P Singer; Daniel R Calabrese; Jasleen Kukreja; John R Greenland Journal: Transpl Infect Dis Date: 2021-02-18
Authors: Daniel T Dugger; Monica Fung; Steven R Hays; Jonathan P Singer; Mary E Kleinhenz; Lorriana E Leard; Jeffrey A Golden; Rupal J Shah; Joyce S Lee; Fred Deiter; Nancy Y Greenland; Kirk D Jones; Chaz R Langelier; John R Greenland Journal: Am J Transplant Date: 2020-09-22 Impact factor: 8.086